{"id":83859,"date":"2026-01-29T13:18:39","date_gmt":"2026-01-29T13:18:39","guid":{"rendered":"https:\/\/www.cofb.org\/?p=83859"},"modified":"2026-01-29T13:18:39","modified_gmt":"2026-01-29T13:18:39","slug":"bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","title":{"rendered":"Bioimpedancia en el consejo farmac\u00e9utico. Qu\u00e9 es y qu\u00e9 nos ofrece"},"content":{"rendered":"

El Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> acogi\u00f3, el pasado 22 de enero, la sesi\u00f3n formativa \u201cBioimpedancia en el consejo farmac\u00e9utico<\/strong>\u201d, con la colaboraci\u00f3n de Microcaya<\/a>. La formaci\u00f3n corri\u00f3 a cargo de Natalia Zaldua<\/strong>, del departamento cient\u00edfico y formativo de Microcaya y experta en bioimpedancia InBody<\/strong>; y de Carla Escuder<\/strong>, farmac\u00e9utica comunitaria y dietista-nutricionista experta en nutrici\u00f3n deportiva. El vocal de Alimentaci\u00f3n y Nutrici\u00f3n de COFB, Oscar Llans\u00f3<\/strong>, coordin\u00f3 y moder\u00f3 la formaci\u00f3n dirigida a farmac\u00e9uticos y farmac\u00e9uticas de farmacia comunitaria.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Los objetivos<\/strong> de la formaci\u00f3n fueron revisar las herramientas para implementar protocolos de consejo alimentario<\/strong>, conocer el funcionamiento y uso de la bioimpedancia y dar el mejor consejo<\/strong> y realizar correctamente la recomendaci\u00f3n nutricional <\/strong>de acuerdo a la composici\u00f3n corporal.<\/p>\n\n\n\n

El vocal de Alimentaci\u00f3n y Nutrici\u00f3n present\u00f3 la formaci\u00f3n, explicando que la bioimpedancia \u201cofrece informaci\u00f3n vital sobre la composici\u00f3n corporal<\/strong>, incluyendo porcentajes de grasa, masa muscular, agua corporal y otros indicadores como el \u00e1ngulo de fase, que son esenciales para la salud y para un buen seguimiento a nivel deportivo\u201d.<\/p>\n\n\n\n

Adem\u00e1s, record\u00f3 que "es el segundo a\u00f1o que se lleva a cabo esta formaci\u00f3n, que contar\u00e1 con una primera parte te\u00f3rica y otra pr\u00e1ctica, con un analizador de composici\u00f3n corporal InBody".<\/p>\n\n\n\n

Qu\u00e9 es y qu\u00e9 ofrece la bioimpedancia<\/h2>\n\n\n\n

En el inicio de su sesi\u00f3n, Carla Escuder<\/strong> explic\u00f3 que \u201cel peso total del cuerpo no lo es todo, sino que la clave est\u00e1 en analizar la composici\u00f3n total del cuerpo<\/strong> y de los compartimentos que lo conforman.\u201d Despu\u00e9s de mostrar im\u00e1genes de dos chicas con un peso id\u00e9ntico<\/strong>, pero con diferencias corporales<\/strong>, la farmac\u00e9utica comunitaria confirm\u00f3 que "su composici\u00f3n es totalmente diferente y tambi\u00e9n su estado de salud. Debido a esto, es clave medir m\u00e1s all\u00e1 del peso total".<\/p>\n\n\n\n

A continuaci\u00f3n, describi\u00f3 la bioimpedancia como \u201cuna t\u00e9cnica que se fundamenta en el principio que los tejidos corporales tienen diferentes conductividades el\u00e9ctricas<\/strong>. Los primeros dispositivos para la bioimpedancia eran rudimentarios pero con el tiempo se mejor\u00f3 la tecnolog\u00eda. Los investigadores empezaron a integrarla en \u00e1mbitos como la nutrici\u00f3n, el deporte y la medicina<\/strong>\u201d.<\/p>\n\n\n\n

\"Carla<\/a>
Carla Escuder durante su presentaci\u00f3n.<\/figcaption><\/figure>\n\n\n\n

Escuder afirm\u00f3 que el \u00cdndice de Masa Corporal (IMC) est\u00e1 ya obsoleto, y dijo que, hoy en d\u00eda, la composici\u00f3n corporal es \u201cel t\u00e9rmino que se utiliza para describir la proporci\u00f3n de los distintos componentes que forman el cuerpo humano, incluida la masa muscular, masa de grasa, agua y otros tejidos\u201d.<\/strong><\/p>\n\n\n\n

Este an\u00e1lisis que ofrece la bioimpedancia \u201cpermite identificar cu\u00e1l cantidad<\/strong>, as\u00ed como la distribuci\u00f3n<\/strong> de estos componentes<\/strong>. Una composici\u00f3n corporal equilibrada, con una proporci\u00f3n saludable de masa magra y grasa corporal, es esencial para el \u00f3ptimo funcionamiento del cuerpo y para prevenir enfermedades cr\u00f3nicas\u201d.<\/p>\n\n\n\n

An\u00e1lisis de la grasa corporal e interpretaci\u00f3n de resultados<\/h2>\n\n\n\n

En cuanto a la parte pr\u00e1ctica de la formaci\u00f3n, Natalia Zaldua<\/strong> explic\u00f3 c\u00f3mo interpretar las hojas de resultados ligadas al'\u00cdndice de Masa Musculoesquel\u00e9tica Apendicular<\/strong> (IMMEA): \u201ceste par\u00e1metro es la suma de la demasiado magra de los brazos<\/strong> y las piernas <\/strong>entre la altura del cuadrado<\/strong>. Se trata de un \u00edndice que refleja el desarrollo muscular<\/strong> y es empleado en la detecci\u00f3n de patolog\u00edas como la sarcopenia\u201d.<\/p>\n\n\n\n

\"Natalia<\/a>
Natalia Zaldua en un momento de su intervenci\u00f3n.<\/figcaption><\/figure>\n\n\n\n

Con relaci\u00f3n a el an\u00e1lisis de la grasa corporal<\/strong>, \u201c\u00e9ste se divide en grasa subcut\u00e1nea y grasa visceral<\/strong>. Este segundo es el que rodea a los \u00f3rganos y que sirve para protegerlos. Es una reserva energ\u00e9tica y un exceso plantea riesgos. Lo ideal es tener un \u00e1rea de grasa visceral inferior al 100%.\u201d A partir de ah\u00ed, la experta en bioimpedancia InBody puso a prueba a todos los farmac\u00e9uticos presentes a trav\u00e9s de la interpretaci\u00f3n de la hoja de resultados <\/strong>del analizador InBody y la evaluaci\u00f3n de las alteraciones en el equilibrio h\u00eddrico<\/strong>, entre otros.<\/p>\n\n\n\n

Para finalizar, Zaldua realiz\u00f3 diferentes recomendaciones antiinflamatorias <\/strong>que pueden sufrir diferentes usuarios, destacando "consolidar el movimiento diario y el ejercicio f\u00edsico, la gesti\u00f3n del estr\u00e9s, llevar a cabo el descanso adecuado, y la regulaci\u00f3n de los ritmos circadiarios, como es evitar el uso de pantallas antes de acostarse y la exposici\u00f3n de luz natural durante la ma\u00f1ana".<\/p>\n\n\n\n

Con la colaboraci\u00f3n de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

El Colegio de Farmac\u00e9uticos de Barcelona acogi\u00f3, el pasado 22 de enero, la sesi\u00f3n formativa "Bioimpedancia en el consejo farmac\u00e9utico", con la colaboraci\u00f3n de Microcaya. La formaci\u00f3n corri\u00f3 a cargo de Natalia Zaldua, del departamento cient\u00edfico y formativo de Microcaya y experta en bioimpedancia InBody; y de Carla [\u2026]<\/p>","protected":false},"author":10,"featured_media":83892,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[36,5254,18,19,5434,271,53,70,46,76],"class_list":["post-83859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-alimentacio","tag-bioimpedancia","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-composicio-corporal","tag-consell-alimentari","tag-farmaceutics","tag-formacio","tag-nutricio","tag-oficina-de-farmacia"],"yoast_head":"\nBioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/es\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/es\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-29T13:18:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavier Magraner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavier Magraner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\"},\"author\":{\"name\":\"Xavier Magraner\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\"},\"headline\":\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix\",\"datePublished\":\"2026-01-29T13:18:39+00:00\",\"dateModified\":\"2026-01-29T13:18:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\"},\"wordCount\":777,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"keywords\":[\"alimentaci\u00f3\",\"bioimped\u00e0ncia\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"composici\u00f3 corporal\",\"consell alimentari\",\"farmac\u00e8utics\",\"Formaci\u00f3\",\"Nutrici\u00f3\",\"Oficina de farm\u00e0cia\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\",\"url\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\",\"name\":\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"datePublished\":\"2026-01-29T13:18:39+00:00\",\"dateModified\":\"2026-01-29T13:18:39+00:00\",\"description\":\"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\",\"name\":\"Xavier Magraner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"caption\":\"Xavier Magraner\"},\"url\":\"https:\/\/www.cofb.org\/es\/author\/xmagraner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/es\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","og_locale":"es_ES","og_type":"article","og_title":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","og_url":"https:\/\/www.cofb.org\/es\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2026-01-29T13:18:39+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","type":"image\/jpeg"}],"author":"Xavier Magraner","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"Xavier Magraner","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/"},"author":{"name":"Xavier Magraner","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4"},"headline":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix","datePublished":"2026-01-29T13:18:39+00:00","dateModified":"2026-01-29T13:18:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/"},"wordCount":777,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","keywords":["alimentaci\u00f3","bioimped\u00e0ncia","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","composici\u00f3 corporal","consell alimentari","farmac\u00e8utics","Formaci\u00f3","Nutrici\u00f3","Oficina de farm\u00e0cia"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","url":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","name":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","datePublished":"2026-01-29T13:18:39+00:00","dateModified":"2026-01-29T13:18:39+00:00","description":"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4","name":"Xavier Magraner","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","caption":"Xavier Magraner"},"url":"https:\/\/www.cofb.org\/es\/author\/xmagraner\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Xavier Magraner","author_link":"https:\/\/www.cofb.org\/es\/author\/xmagraner\/"},"uagb_comment_info":0,"uagb_excerpt":"El Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir, el passat 22 de gener, la sessi\u00f3 formativa \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya. La formaci\u00f3 va anar a c\u00e0rrec de Natalia Zaldua, del departament cient\u00edfic i formatiu de Microcaya i experta en bioimped\u00e0ncia InBody; i de Carla […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/83859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=83859"}],"version-history":[{"count":24,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/83859\/revisions"}],"predecessor-version":[{"id":83936,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/83859\/revisions\/83936"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/83892"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=83859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=83859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=83859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}